We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+16.98%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$295B
AUM Growth
+$35.4B
(+14%)
Cap. Flow
-$1.58B
Cap. Flow
% of AUM
-0.53%
Top 10 Holdings %
Top 10 Hldgs %
22.42%
Holding
3,425
New
145
Increased
1,798
Reduced
1,253
Closed
125
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1B |
| 2 |
Apple
AAPL
|
+$797M |
| 3 |
Merck
MRK
|
+$316M |
| 4 |
Amazon
AMZN
|
+$308M |
| 5 |
Medtronic
MDT
|
+$298M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$587M |
| 2 |
NXP Semiconductors
NXPI
|
+$554M |
| 3 |
Meta Platforms (Facebook)
META
|
+$449M |
| 4 |
Intuit
INTU
|
+$433M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.73% |
| 2 | Healthcare | 13.29% |
| 3 | Consumer Discretionary | 13.23% |
| 4 | Financials | 12.2% |
| 5 | Communication Services | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Genesco
GCO
$422M
| $3.74M | ﹤0.01% |
124,311
-3,740
| -3% | -$95.6K |
|
2202
Franklin Covey
FC
$246M
| $3.69M | ﹤0.01% |
165,900
-21,709
| -12% | -$452K |
|
2203
Enanta Pharmaceuticals
ENTA
$400M
| $3.68M | ﹤0.01% |
87,473
-3,114
| -3% | -$137K |
|
2204
JFrog
FROG
$10.8B
| $3.68M | ﹤0.01% |
+58,621
| New | +$4.09M |
|
|
SWI
2205
DELISTED
SolarWinds Corporation Common Stock
SWI
| $3.68M | ﹤0.01% |
233,399
+125,001
| +115% | +$2.74M |
|
|
AD
2206
Array Digital Infrastructure
AD
$3.05B
| $3.66M | ﹤0.01% |
119,175
-58,715
| -33% | -$1.79M |
|
2207
Peapack-Gladstone Financial
PGC
$812M
| $3.65M | ﹤0.01% |
160,541
-22,244
| -12% | -$441K |
|
|
CNCE
2208
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $3.64M | ﹤0.01% |
287,910
-906
| -0.3% | -$10.3K |
|
2209
TechnipFMC
FTI
$27.3B
| $3.63M | ﹤0.01% |
519,393
+115,138
| +28% | +$677K |
|
|
AVID
2210
DELISTED
Avid Technology Inc
AVID
| $3.62M | ﹤0.01% |
228,095
+68,608
| +43% | +$768K |
|
|
DCPH
2211
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $3.62M | ﹤0.01% |
181,390
-403
| -0.2% | -$23.9K |
|
|
CVA
2212
DELISTED
Covanta Holding Corporation
CVA
| $3.6M | ﹤0.01% |
522,103
-250
| -0% | -$2.7K |
|
2213
Winmark
WINA
$1.32B
| $3.6M | ﹤0.01% |
19,387
-2,204
| -10% | -$392K |
|
2214
Liberty Energy
LBRT
$3.25B
| $3.59M | ﹤0.01% |
348,524
+69,809
| +25% | +$636K |
|
2215
CoreCivic
CXW
$3.19B
| $3.58M | ﹤0.01% |
546,000
-16,570
| -3% | -$119K |
|
|
TAST
2216
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $3.57M | ﹤0.01% |
568,659
-74,741
| -12% | -$478K |
|
2217
Ecovyst
ECVT
$1.14B
| $3.57M | ﹤0.01% |
250,353
+59,192
| +31% | +$751K |
|
|
DCT
2218
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
| $3.57M | ﹤0.01% |
82,354
+32,111
| +64% | +$1.36M |
|
2219
UroGen Pharma
URGN
$2.29B
| $3.56M | ﹤0.01% |
197,690
-42,558
| -18% | -$892K |
|
|
CONN
2220
DELISTED
Conn's Inc.
CONN
| $3.56M | ﹤0.01% |
304,391
-273,303
| -47% | -$3.11M |
|
2221
Murphy Oil
MUR
$4.78B
| $3.54M | ﹤0.01% |
292,815
-25,617
| -8% | -$255K |
|
2222
Vanguard FTSE Developed Markets ETF
VEA
$237B
| $3.54M | ﹤0.01% |
75,000
| – | – |
|
2223
iShares Core S&P 500 ETF
IVV
$904B
| $3.52M | ﹤0.01% |
9,390
-141,834
| -94% | -$50.5M |
|
2224
Korro Bio
KRRO
$195M
| $3.52M | ﹤0.01% |
1,998
+4
| +0.2% | +$5.28K |
|
2225
Madrigal Pharmaceuticals
MDGL
$11.8B
| $3.52M | ﹤0.01% |
31,671
-1,720
| -5% | -$210K |
|
Similar funds
VFT
Nuveen's Q4 2020 Portfolio in Review
As of Q4 2020, Nuveen held 3,425 positions worth $295B, up 14% from $260B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Nuveen's Q4 2020 filing shows 145 new, 1,798 increased, 1,253 reduced and 125 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M. The largest sale was Walt Disney, an estimated $587M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Nuveen's largest Q4 2020 buy was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M.
- Nuveen added most to Microsoft in Q4 2020, an estimated $1B increase.
- Nuveen's biggest Q4 2020 reduction was Walt Disney, cutting an estimated $587M.
- Nuveen fully exited Alcon in Q4 2020, selling an estimated $174M.
- Nuveen's ten largest holdings make up 22% of its $295B portfolio in Q4 2020.
- Nuveen opened 145 new positions and closed 125 in Q4 2020.
- Nuveen's portfolio value rose 14% quarter-over-quarter to $295B.
Based on Nuveen's 13F filing for Q4 2020, filed 16 Feb 2021.